Cardiff Oncology, Inc.

CRDF·NasdaqCM·Healthcare
Compare
0.8689+0.0058 (+0.67%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.8631
Open0.8674
Day range0.84350.9000
52-week range0.76003.3100
Off day high−3.46%
Off 52-week high−73.75%
Volume289.02K
Avg. volume (3M)636.35K
Market cap67.60M
EPS (TTM)-0.6000
Forward P/E-1.62
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.56
Shares outstanding77.80M
Short interest15.91% of float
Earnings dateAug 11, 2026 (est.)
Analyst target6.2833
Profit margin0.00%

Against its peers

Compare in full ›
CRDF BBOT APLM SPRINT.ST HBP.TO NBP
Market cap 67.60M 184.40M 55.38M 370.36M 70.27M 117.16M
P/E (TTM) — — — 5.0 — —
Forward P/E -1.6 -0.8 -29.2 2.7 -8.4 -0.8
Price/book 2.2 0.6 -12.8 4.1 4.8 0.6
Dividend yield — — — — — —
1-year change −61.33% −81.22% +71.38% +380.72% −54.68% −75.89%
Today +0.67% −0.86% −8.83% +0.57% 0.00% 0.00%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All CRDF news ›
Oncodaily - Oncology News·Positive

Yorkshire Cancer Research–Sheffield Pioneers Funding 2027

OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by…

Morningstar·Positive

Cardiff Oncology Inc CRDF

Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1…

markets.businessinsider.com·Positive

Cardiff Oncology to Participate in September 2026 Conferences

SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhi... Cardiff Oncology to Participate in September 2026 Conferences SAN DIEGO, Sept. 02, 2026…

AZN
markets.businessinsider.com·Positive

Cardiff Oncology upgraded to Buy from Neutral at H.C. Wainwright

H.C. Wainwright upgraded Cardiff Oncology (CRDF) to Buy from Neutral with a $9 price target The company reached a settlement with Nerviano and ... Cardiff Oncology upgraded to Buy from Neutral at H.C. Wainwright H.C. Wainwright upgraded…

From the 4Search news index, newest first.

In the news

12mentions in 30 days
12with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance